Funding Opportunity: Comprehensive Geriatric Assessment (CGA)

Mixed consortia of robot manufacturers and research institutes have the opportunity to apply for a total funding of 1.2 million Euros in a competitive process in order to develop small-scale test series as solutions for the given challenge. AQuAS (Agència de Qualitat I Avaluació Sanitàries de Catalunya), a public entity of the Catalan Department of Health, and Fundació Privada Sant Antoni Abat, a non-profit private foundation managing and developing innovation and research in healthcare, have defined the Comprehensive Geriatric Assessment (CGA) challenge. This challenge specifies the requirements of the public bodies for a robotic product that is not yet available on the market.

The Comprehensive Geriatric Assessment (CGA) is a diagnostic instrument designed to collect data on the medical, psychosocial and functional resources and problems of elderly patients. The information gathered is used to create a plan for treatment and followup. Currently, CGA is performed by social and clinical professionals involved in the care of elderly people: physiotherapists, occupational therapists, nurses, social workers, psychologists, medical doctors, etc. The goal of utilizing a robot to control and to conduct the geriatric tests is to reduce the amount of time medical professionals spend on taking tests and thereby enable them to invest this time oncare planning decisions. In order to master this challenge, multi-institutional consortia or development teams will need to apply for funding in a competitive process in order to develop prototypes according to the needs of the public bodies.

The aim of ECHORD++ (European Clearing House for Open Robotics Development Plus Plus) is to strengthen the knowledge transfer between scientific research, industry and users in robotics and to stimulate their cooperation. The EU-funded project with a runtime of five years (2013 - 2018) funds small-scale research projects called experiments, Public end-user Driven Technological Innovation (PDTI), and established Robotics Innovation Facilities (RIFs), open labs which provide state-of-the-art robotic hardware and software as well as scientific and technical support. ECHORD++ is a joint project of Technische Universität München (project coordinator), Blue Ocean Robotics, Bristol Robotics Laboratory, Commissariat à l’Énergie Atomique et aux Énergies Alternatives, R.U. Robots, Scuola Superiore Sant’Anna, TechnoDeal and Universitat Politècnica de Catalunya.

The idea behind Public end-user Driven Technological Innovation (PDTI) in ECHORD++ is to include public bodies in the robotic product development. By acting as technologically demanding first buyers, public procurers can drive innovation from the demand side and promote the transfer of robotic technology from research to the market. Since public bodies often have specific requirements for the products they use, ECHORD++ will strive to find the best way to integrate them in the product development process. This is to make sure that the product meets the requirements of the target group, technically and price-wise. Thus, ECHORD++ hopes to close the innovation gap between what is available on the market and the public sector's needs.

Closing date: 23rd June 2015

For further information about PDTI, please visit:
http://www.echord.eu/pdti/

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Tel.: +49 89 289 18136

The project ECHORD++ is funded under EU’s Seventh Framework Programme for Research (FP7), Grant Agreement No. 601116.

Most Popular Now

Novartis and Microsoft Announce Collabor…

Novartis announced an important step in reimagining medicine by founding the Novartis AI innovation lab and by selecting Microsoft as its strategic AI and data-science partner for this effort. The...

Guerbet and IBM Watson Health Announce a…

Guerbet, a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, announced that it has signed a new agreement with IBM Watson Health to co-develop and...

Bayer Inks Deals with Eleven Startups un…

Bayer announced today that the company has signed collaboration agreements with eleven digital health startups. As part of the program, Bayer will support these startup companies aiming for longer-term collaborations...

Orion Health Delivers the First Health I…

The first Health Information Exchange (HIE) in the Middle East, Malaffi, went live at the end of July just six months after contracts were signed between the project company, Abu...

Joined Up Health and Care 2019 to Explor…

Professionals from across the country will come together to seek real answers on how to deliver closely integrated services, as the Joined Up Health and Care conference returns for its...

IMS MAXIMS Wins Healthcare Innovation Aw…

Health technology specialist IMS MAXIMS has been recognised for its innovative work in the UK and Irish healthcare market in the 2019 CV Business Innovator Awards. The company has been...

Almirall Takes a Leap into Dermatology D…

Almirall, S.A. (ALM) has launched its first call for innovation to start-ups focused on dermatology digital health. This initiative is the first step in the creation of an accelerator programme...

Health Tech Marketing and PR Agency Incr…

Highland Marketing, a full service agency for health techmarketing, PR and communications, has appointed Tia Dissanayake to a new account executive role,in which she will support the team withher life...

Brain-Computer Interfaces without the Me…

It sounds like science fiction: controlling electronic devices with brain waves. But researchers have developed a new type of electroencephalogram (EEG) electrode that can do just that, without the sticky...

Up-Close and Personal with Neuronal Netw…

How our brain cells, or neurons, use electrical signals to communicate and coordinate for higher brain function is one of the biggest questions in all of science. For decades, researchers...